Today: 9 June 2026
Browse Category

LSE:MRO 1 December 2025 - 6 June 2026

FTSE Opens Up as Oil Moves, But Investors on Watch

FTSE Opens Up as Oil Moves, But Investors on Watch

The FTSE 100 rose 0.86% to 10,556.60 after the spring bank holiday, led by gains in Kingfisher and oil-linked stocks. Kingfisher reported a 0.7% drop in first-quarter like-for-like sales but kept its profit target. Brent crude climbed over 2% to $98.21 after U.S. strikes in southern Iran. UK shop prices rose 1.2% in May from a year earlier, the British Retail Consortium said.
26 May 2026
··········
UK stock market today: FTSE 100 closes higher as NatWest buyback lifts banks; Pinewood tumbles

UK stock market today: FTSE 100 closes higher as NatWest buyback lifts banks; Pinewood tumbles

Britain’s FTSE 100 closed up 0.3% at 10,473.69 on Monday, led by NatWest’s 4.8% jump after it launched a £750 million buyback. Defence stocks gained as Prime Minister Keir Starmer called for faster defence spending. The FTSE 250 fell 0.2%, dragged by Pinewood Technologies’ 33% plunge after Apax Partners withdrew. SkinBioTherapeutics tumbled 45% after warning of a major earnings hit.
16 February 2026
······
UK Stock Market Today: FTSE 100 Faces Soft December 1 Open as Budget Fallout and BoE Rate‑Cut Bets Shape Sentiment

UK Stock Market Today: FTSE 100 Faces Soft December 1 Open as Budget Fallout and BoE Rate‑Cut Bets Shape Sentiment

FTSE 100 futures signal a drop of 10–16 points to around 9,705 at Monday’s open, following a 4.7% slide in Bitcoin and weak Asian manufacturing data. The index closed Friday at 9,720.51, up 0.27% on the day and 17.7% higher year-to-date, after hitting record highs in November.
1 December 2025
·······

Stock Market Today

  • AmpliTech Shares Surge 26.7% on 5G Open RAN Testing Update
    June 9, 2026, 9:16 AM EDT. AmpliTech (AMPG) shares surged 26.7% to $6.57 following its Open RAN testing update at the O-RAN Alliance Global PlugFest Spring 2026. The company's 64T64R Massive MIMO radio, which uses multiple antennas to enhance wireless capacity, was the only one of its kind tested with equipment from major operators including AT&T and Deutsche Telekom. Despite the strong test results, no new sales orders were announced, leaving investors cautious about future revenue impact. AmpliTech reported a 48.6% increase in first-quarter revenue to $5.35 million but remains unprofitable, narrowing its net loss to $1.52 million. The firm holds $18.4 million in cash and securities. Open RAN aims to enable multi-vendor interoperability in 5G networks, a critical push in telecom infrastructure modernization.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Go toTop